Delivery Order SPE2DB25D3012-SPE2DB25FWXVS
Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, valued at $9,340.07, with a firm fixed price and an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $20,483.72 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency awarded a $5,935.94 delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical situations. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials with a ceiling value of $13,023.58. The contract was competitively awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizing firm fixed pricing under a non-set-aside contract type. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, valued at $12,474.24 under a firm fixed-price contract. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,019.04 to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This firm fixed price contract, awarded on June 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,156.22 to supply Activase 50 mg vials, a thrombolytic medication used in emergency medical settings. The delivery order, issued on June 2, 2025, represents a firm fixed price contract with an ultimate completion date of June 3, 2025, and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded a $41,605.34 delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. The contract, which became effective on September 15, 2025, with completion targeted for September 16, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...